CELLULAR AND MOLECULAR LIFE SCIENCES

Journal Title
CELLULAR AND MOLECULAR LIFE SCIENCES

CELL MOL LIFE SCI

ISSN / eISSN
1420-682X / 1420-9071
Aims and Scope
Based in Basel, Switzerland, the multidisciplinary journal Cellular and Molecular Life Sciences (CMLS) publishes research articles, reviews, multi-author reviews and visions & reflections articles covering the latest aspects of biological and biomedical research. The journal will consider contributions focusing on biochemistry and molecular biology, cell biology, molecular and cellular aspects of biomedicine, neuroscience, pharmacology and immunology. In addition, CMLS welcomes comments on any article published in CMLS, as well as suggestions for topics to be covered.
Subject Area

BIOCHEMISTRY & MOLECULAR BIOLOGY

CELL BIOLOGY

CiteScore
12.80 View Trend
CiteScore Ranking
Category Quartile Rank
Pharmacology, Toxicology and Pharmaceutics - Pharmacology Q1 #17/301
Pharmacology, Toxicology and Pharmaceutics - Molecular Medicine Q1 #16/171
Pharmacology, Toxicology and Pharmaceutics - Molecular Biology Q1 #40/380
Pharmacology, Toxicology and Pharmaceutics - Cellular and Molecular Neuroscience Q1 #10/90
Pharmacology, Toxicology and Pharmaceutics - Cell Biology Q1 #38/274
Web of Science Core Collection
Science Citation Index Expanded (SCIE) Social Sciences Citation Index (SSCI)
Indexed -
Category (Journal Citation Reports 2023) Quartile
BIOCHEMISTRY & MOLECULAR BIOLOGY - SCIE Q1
CELL BIOLOGY - SCIE Q1
H-index
194
Country/Area of Publication
SWITZERLAND
Publisher
Springer International Publishing
Publication Frequency
Semimonthly
Year Publication Started
1945
Annual Article Volume
578
Open Access
NO
Contact
BIRKHAUSER VERLAG AG, VIADUKSTRASSE 40-44, PO BOX 133, BASEL, SWITZERLAND, CH-4010
Verified Reviews
Note: Verified reviews are sourced from across review platforms and social media globally.
I submitted a molecular biology gene editing method. This manuscript was previously rejected by Molecular Therapy. The quality of the first review response of this journal is much stronger than that of Molecular Therapy. The editing process is fast, and the professionalism and attentiveness of the reviewers are greatly appreciated. I submitted it at the end of July and received the first comments in less than 20 working days, allowing three months for major revisions. Due to the long experimental cycle, we applied for a one-month extension. We submitted it again around December 20th and received a reply in early January. Both reviewers were very satisfied with our additional experiments and text. After a minor revision, it was accepted for publication. Overall, the experience of submitting to this journal was very good, with the editors being very careful and efficient. The manuscript never stayed in the editor's hands for more than a day. I welcome everyone to submit more and promote this journal to the top tier.
2022-01-17
This is the most speechless magazine I have ever submitted. It stayed "under review" for three months. I sent a reminder letter asking about the progress, but the editor replied asking me to wait for news without saying anything. I waited for another half a month and sent another reminder letter, but the editor replied with the exact same response, asking me to continue waiting for news without providing any information. After four months, I couldn't wait any longer and sent another reminder letter, and the next day I was rejected. One of the reviewers provided some comments, while the other one didn't say much. Anyway, I will never submit to this magazine again. The editor is too arrogant.
2022-11-29

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started